Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
18 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/simcere-zaiming-announces-first-patient-dosed-in-the-us-in-a-phase-1-trial-of-trispecific-antibody-sim0500-in-patients-with-relapsedrefractory-multiple-myeloma-302485872.html
17 Jun 2025
// BIOSPACE
https://www.biospace.com/business/nextcure-joins-china-adc-gold-rush-with-745m-simcere-deal
18 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fermion-and-simcere-enter-into-an-exclusive-license-and-collaboration-agreement-for-chinas-first-sstr4-agonist-targeting-pain-302354671.html
17 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fermion-and-simcere-enter-into-an-exclusive-license-and-collaboration-agreement-for-chinas-first-sstr4-agonist-targeting-pain-302354671.html
14 Jan 2025
// PRESS RELEASE
https://news.abbvie.com/2025-01-13-AbbVie-and-Simcere-Zaiming-Announce-Partnership-to-Develop-a-Novel-Trispecific-Antibody-Candidate-in-Multiple-Myeloma
04 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/china-nmpa-approves-simceres-sanbexin-sublingual-tablets-for-the-treatment-of-acute-ischemic-stroke-302322300.html
ABOUT THIS PAGE
Simcere Pharmaceutical is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Iguratimod bulk with JDMF offered by Simcere Pharmaceutical
Find a price of Dioctahedral smectite bulk offered by Simcere Pharmaceutical